BiotechTubeBiotechTube
Home/Abeona Therapeutics/Brian Kevany, Ph.D.
BK

Brian Kevany, Ph.D.

Chief Technical Officer & Chief Scientific Officer

Abeona Therapeutics

Therapeutic Areas

Rare DiseasesInherited Retinal DiseasesNeurological Disorders

Abeona Therapeutics Pipeline

DrugIndicationPhase
ZEVASKYN®Not specified (Commercial Product)Approved/Commercial
ABO-503X-Linked Retinoschisis (XLRS)Preclinical
ABO-504Stargardt DiseasePreclinical
ABO-505Autosomal Dominant Optic Atrophy (ADOA)Preclinical
UX111Sanfilippo Syndrome Type A (MPS IIIA)Phase 1/2
TSHA-102Rett SyndromePhase 1/2

Leadership Team at Abeona Therapeutics

VS
Vishwas Seshadri, Ph.D., M.B.A.
Chief Executive Officer, Director
View full Abeona Therapeutics profile